Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

MASSACHUSETTS: AIDS Center's New Labs Debut: US Cuts May Slow Hunt for a Vaccine


Boston Globe (03.12.13)

On March 11, the Ragon Institute, funded by “software magnate” Phillip Terrence Ragon, opened a new $30 million research facility that is designed to facilitate collaboration among physicians, physicists, and engineers in developing HIV vaccines and studying TB. The 75,000-square-foot Cambridge, Mass., building, which now houses 175 staff members, is large enough to allow the staff to double in size and to accommodate visiting scientists as well. Philanthropists Mark and Lisa Schwartz will provide $50,000 grants to outside scientists, which will enable them to participate in the Ragon Institute’s research. The institute’s director, Dr. Bruce Walker, explained that interaction among disciplines has already resulted in innovative approaches to developing HIV vaccines. Massachusetts Institute of Technology engineers used a math model typically used in finance to pinpoint “stable regions” of the HIV virus that can be targeted by vaccines. The Institute plans to test the HIV vaccines using microscopes that display 3-D images, showing how immune cells attack the virus. New technology at the institute also includes cell-sorting machines that can be used to isolate white blood cells from people who have demonstrated naturally occurring HIV resistance. Although the institute’s research is “high risk,” Walker emphasized that the Ragon Institute’s research will be broadly applicable. Researchers at Ragon Institute are more and more dependent on private donors as federal funding becomes less available from the National Institutes of Health (NIH). Whereas NIH funded 33 to 36 percent of grant applications 10 years ago, it now funds only 18 percent of applications. NIH uses a peer-review process to select grant applications for funding. NIH funding for projects at Ragon Institute was cut by five percent in anticipation of sequestration, and funding cuts may be increased by up to 10 percent in the coming fiscal year if sequestration becomes permanent.


Copyright © 2013 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in March 12, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.